Top Markets
Coin of the day
Lumos Diagnostics Holdings Limited Lumos Diagnostics Holdings Limited

Lumos Diagnostics Holdings Limited

LDX
Rank in Stocks #23727
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes... Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.
Share Price
$0.0740549
Last synced: 2026-08-21
Market Cap
$69.97M
Change (1 day)
0.00%
Change (1 year)
21.33%
Country
AU
Trade Lumos Diagnostics Holdings Limited (LDX)

Category

Operating Margin for Lumos Diagnostics Holdings Limited (LDX)
Operating Margin as of 2026 TTM: 0.00%
According to Lumos Diagnostics Holdings Limited latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Lumos Diagnostics Holdings Limited from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
18.91% -
IE
0.00% -
CN
0.00% -
CH
0.00% -
CH
0.00% -
CN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.